Abstract
We studied the activity of two enzymes NSE and TK in the biological fluids of 104 patients with nervous system diseases, who fell into 4 groups. 20 subjects out of 35 in the tumor group had glial tumors. We fixed a cut-off value of NSE and TK activity at the 95th percentile of the control group, both in serum and in CSF. The aim of our investigation was to assess the reliability of TK and NSE assays in separating brain tumors from other neurological diseases. In our patients, most of the TK activity above the cut-off value was found in the tumor group. Serum TK seems to be a useful marker for following up cerebral tumors after surgery, but NSE is less useful for this purpose.
Sommario
Abbiamo studiato l'attività di due enzimi NSE e TK nei liquidi biologici di 104 Pazienti affetti da patologie del sistema nervoso. I Pazienti sono stati divisi in quattro gruppi: dei 35 Pazienti affetti da neoplasie 20 erano portatori di un tumore della serie gliale.
Su liquor e su siero il valore cut-off dell'attività di NSE e TK è stato fissato al 95o percentile del gruppo controllo. Lo scopo del nostro studio è stato quello di stabilire la affidabilità del dosaggio della NSE e della TK nel separare i tumori cerebrali da altre patologie d'interesse neurologico. Nei nostri Pazienti la maggiore attività enzimatica al di sopra del valore cut-off è stata riscontrata nel gruppo tumorale.
I livelli serici di TK sembrano essere un utile marker per la valutazione del follow-up post-chirurgico dei Pazienti affetti da tumore gliale, mentre la valutazione dei valori della NSE non sembra utile a tale scopo.
Similar content being viewed by others
References
Bombardieri E., Cocciolo M., Seregni E., Pizzorno B.:Valutazione dell'aggressività biologica della neoplasia mediante la misura della attività Timidina-chinasica nel siero. Argomenti di Oncologia 8:37–45, 1987.
Dhillon A.P., Rode J., Leathman A.:Neuronspecific enolase: an aid to diagnosis of melanoma and neuroblastoma. Histopathology 6:81–92, 1982.
Ellims P.H., Gan T.E., Van Der Weyden M.B.:Fetal Tymidine kinase (TK1) in hairy cell leukemia. Scan. J. Hematol, 30:141–145, 1983.
Gronowitz J.S., Kallander C.F.R., Hagberg H., Persson L.:Deoxithimidine Kinase in cerebrospinal fluid: a new potential marker for brain tumors. Acta Neurochir. 73, 1–12, 1982.
Gronowitz J.S., Kallander C.F.R.:Optimized assay for thymidine kinase and its application for detection of antibodies against kinase. Infect. Immunol., 29, 425–434, 1980.
Hagberg H., Gronowitz J.S., Kallander A., Kallander C.F.R.:Serum Thymidine kinase in vitamin B12 deficienty. Scand. J. Haematol., 32:41–45, 1984.
Ishiguro Y., Kato K., Shimizu A., Ito, T., Nagaya M.:High levels of immunoreactivye nervous system specific enolase in serta of patients with neuroblastoma. Clin. Chim. Acta, 121:173–180, 1982.
Jonhson D., Maragons P.Y., Forbers J.T., Greco F.A.:Potential utility of serum neurospecific enolase levels in small-cells carcinoma of the lung. Cancer Res., 44:5409–5414, 1984.
Kallander C.F.R., Gronowitz J.S., Olding-Stenkvist E.:Rapid diagnosis of varicella zoster virus infection by detection of viral deoxythymidin kinase in serum and visceral fluid. J. Clin. Microbiol, 17:280–287, 1983.
Kallander C.F.R., Simonsson B., Gronowitz J.S.:Serum deoxythymidine kinase gives prognostic information in chronic lymphochytic leukemia. Cancer, 54:2450–2455, 1984.
Karney D., Maragons P., Ihide D., Bunn P., Cohen M., Minn D., Gazdar A.:Serum neuronspecific enolase: a marker for disease extent and response to therapy of small-cells lung cancer. Lancet, 1:583–585, 1982.
Mokuno K., Kato K., Matsoula Y., Yanagi T., Soube I.:Neurospecific enolase and S100 protein levels in CSF of patients with various neurological diseases. J. Neurol. Sci. 60:443–451, 1983.
Odelstad L., Pohlman S., Nilsson K.:Neuronspecific enolase in relation to differentiation in human neuroblastoma. Brain Res. 224:69–82, 1981.
Persson L., Boethius J., Gronowitz J.S., Kallander C., Lindegren I.:Thimidine Kinase in brain tumor cysts. J. Neurosurg. 63:568–572, 1985.
Persson L., Gronowitz S.J., Kallander C.F.R.:Thymidine kinase in extracts of human brain tumors. Acta Neurochir. 80:123–127, 1986.
Pharmacia Diagnostics AB:Pharmacia NSE RIA, Radioimmunoassay, 1988.
Royds J.A., Davies-Jones B., Lewtas N.A., Timperley W.R., Taylor B.C.:Enolase isoenzymes in the CFS of patients with diseases of the nervous system. J. Neurol. Neurosurg. Psychiatry 46:1031–1036, 2983.
Royds J.A., Ironside J.W., Taylor B.C., Graham D.I., Timperley W.R.:An immunohistochemical study of glial and neuronal markers in primary neoplasms of the central nervous system. Acta Neuropathol. (Berl.) 70:320–326, 1986.
Royds J.A., Timperley R.W., Taylor C.:Levels of enolase and other enzymes in cerebrospinal fluid as incides of pathological change. J. Neurol. Neurosurg. Psichiatry 44:1129–1135, 1981.
Sangtec Medical:Prolifigen TK-REA radioenzyme assay for thimidine kinase, 1988.
Schmechel D., Marangos P., Brightam M.:Neuron-specific enolase is a molecular marker for peripheral and central neorendocrine cells. Nature 276:834–836, 1978.
Tapia F.J., Polak M.J., Barbose A.J., Bloom B.S., Marangos P.J., Dermody C., Peraser A.G.E.:Neuron-specific enolase is produced by neuroendocrine tumors. Lancet i:808–811, 1981.
Vinores S.A., Bonnin J.M., Rubistein J. andMarangos P.J.:Himmunohistochemical demonstration of neuro-specific enolase in neoplasm of CNS and other tissue. Arch. Pathol. Lab. Med. 108:536–540, 1984.
Vinores S.A., Herman M., Rubistein L.:Electron immunocytochemical localisation of neuronspecific enolase cytoplasm and on membranes of primary and metastatic cerebral tumors and on glial filaments of glioma cells. Histopathology 10:891–908, 1986.
Vinores S.A., Marangos I.J., Bonnin M., Rubistein L.J.:Immunoradiometric and immunohistochemical demonstration of neuron specific enolase in experimental rat gliomas. Cancer Res. 44:2595–2599, 1984.
Vinores S.A., Rubistein L.J.:Simultaneous expression of glial fibrillary acid protein (GFAP) and neuron-specific enolase (NSE) by the same reactive and neoplastic astroctyes. Neuropathol. Appl. Neurobiol. 11:349–359, 1985.
Zelter P.M., Marangos P.L., Parme A.M., Sorther A., Dalton A., Hammon D., Siegel S., Seegar R.:Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. Lancet 11:361–363, 1983.
Zhang H.J., Kennedy B.J., Kiang D.T.:Tymidine kinase as a predictor of response to chemotherapy in advanced breast cancer. Breast Cancer Res. Treat. 4:221–225, 184.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boiardi, A., Munari, L., Silvani, A. et al. Neuron specific enolase (NSE) and thymidine kinase (TK) as markers in biological fluids of brain tumor patients. Ital J Neuro Sci 11, 359–366 (1990). https://doi.org/10.1007/BF02335938
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02335938